Literature DB >> 22345078

Involvement of hnRNP A1 in the matrix metalloprotease-3-dependent regulation of Rac1 pre-mRNA splicing.

Federico Pelisch1, Davitte Khauv, Guillermo Risso, Melody Stallings-Mann, Matías Blaustein, Leandro Quadrana, Derek C Radisky, Anabella Srebrow.   

Abstract

Rac1b is an alternatively spliced isoform of the small GTPase Rac1 that includes the 57-nucleotide exon 3b. Rac1b was originally identified through its over-expression in breast and colorectal cancer cells, and has subsequently been implicated as a key player in a number of different oncogenic signaling pathways, including tumorigenic transformation of mammary epithelial cells exposed to matrix metalloproteinase-3 (MMP-3). Although many of the cellular consequences of Rac1b activity have been recently described, the molecular mechanism by which MMP-3 treatment leads to Rac1b induction has not been defined. Here we use proteomic methods to identify heterogeneous nuclear ribonucleoprotein (hnRNP) A1 as a factor involved in Rac1 splicing regulation. We find that hnRNP A1 binds to Rac1 exon 3b in mouse mammary epithelial cells, repressing its inclusion into mature mRNA. We also find that exposure of cells to MMP-3 leads to release of hnRNP A1 from exon 3b and the consequent generation of Rac1b. Finally, we analyze normal breast tissue and breast cancer biopsies, and identify an inverse correlation between expression of hnRNP A1 and Rac1b, suggesting the existence of this regulatory axis in vivo. These results provide new insights on how extracellular signals regulate alternative splicing, contributing to cellular transformation and development of breast cancer.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22345078      PMCID: PMC3927408          DOI: 10.1002/jcb.24103

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  60 in total

1.  Human hnRNP protein A1 gene expression. Structural and functional characterization of the promoter.

Authors:  G Biamonti; M T Bassi; L Cartegni; F Mechta; M Buvoli; F Cobianchi; S Riva
Journal:  J Mol Biol       Date:  1993-03-05       Impact factor: 5.469

2.  Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis.

Authors:  E Stickeler; F Kittrell; D Medina; S M Berget
Journal:  Oncogene       Date:  1999-06-17       Impact factor: 9.867

3.  The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.

Authors:  M D Sternlicht; A Lochter; C J Sympson; B Huey; J P Rougier; J W Gray; D Pinkel; M J Bissell; Z Werb
Journal:  Cell       Date:  1999-07-23       Impact factor: 41.582

Review 4.  The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.

Authors:  M D Sternlicht; M J Bissell; Z Werb
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

5.  Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.

Authors:  Vânia Gonçalves; Paulo Matos; Peter Jordan
Journal:  Hum Mol Genet       Date:  2009-07-13       Impact factor: 6.150

6.  Subcellular relocalization of a trans-acting factor regulates XIAP IRES-dependent translation.

Authors:  Stephen M Lewis; Anne Veyrier; Nicoleta Hosszu Ungureanu; Sophie Bonnal; Stéphan Vagner; Martin Holcik
Journal:  Mol Biol Cell       Date:  2007-02-07       Impact factor: 4.138

7.  B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival.

Authors:  Paulo Matos; Carla Oliveira; Sérgia Velho; Vânia Gonçalves; Luís Teixiera da Costa; Mary Pat Moyer; Raquel Seruca; Peter Jordan
Journal:  Gastroenterology       Date:  2008-05-22       Impact factor: 22.682

8.  Increased Rac1b expression sustains colorectal tumor cell survival.

Authors:  Paulo Matos; Peter Jordan
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

9.  An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype.

Authors:  Irina M Shapiro; Albert W Cheng; Nicholas C Flytzanis; Michele Balsamo; John S Condeelis; Maja H Oktay; Christopher B Burge; Frank B Gertler
Journal:  PLoS Genet       Date:  2011-08-18       Impact factor: 5.917

10.  Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression.

Authors:  C J Sympson; R S Talhouk; C M Alexander; J R Chin; S M Clift; M J Bissell; Z Werb
Journal:  J Cell Biol       Date:  1994-05       Impact factor: 10.539

View more
  34 in total

1.  SPSB1-mediated HnRNP A1 ubiquitylation regulates alternative splicing and cell migration in EGF signaling.

Authors:  Feng Wang; Xing Fu; Peng Chen; Ping Wu; Xiaojuan Fan; Na Li; Hong Zhu; Ting-Ting Jia; Hongbin Ji; Zefeng Wang; Catherine C L Wong; Ronggui Hu; Jingyi Hui
Journal:  Cell Res       Date:  2017-01-13       Impact factor: 25.617

Review 2.  Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics.

Authors:  Manti Guha; Narayan G Avadhani
Journal:  Mitochondrion       Date:  2013-09-01       Impact factor: 4.160

3.  Tumor cell-derived MMP3 orchestrates Rac1b and tissue alterations that promote pancreatic adenocarcinoma.

Authors:  Christine Mehner; Erin Miller; Davitte Khauv; Aziza Nassar; Ann L Oberg; William R Bamlet; Lizhi Zhang; Jens Waldmann; Evette S Radisky; Howard C Crawford; Derek C Radisky
Journal:  Mol Cancer Res       Date:  2014-05-21       Impact factor: 5.852

4.  Both sides of the same coin: Rac1 splicing regulating by EGF signaling.

Authors:  Xiang-Dong Fu
Journal:  Cell Res       Date:  2017-02-10       Impact factor: 25.617

Review 5.  Influence of transcriptional variants on metastasis.

Authors:  Joice De Faria Poloni; Diego Bonatto
Journal:  RNA Biol       Date:  2018-07-24       Impact factor: 4.652

6.  Matrix metalloproteinase induction of Rac1b, a key effector of lung cancer progression.

Authors:  Melody L Stallings-Mann; Jens Waldmann; Ying Zhang; Erin Miller; Mona L Gauthier; Daniel W Visscher; Gregory P Downey; Evette S Radisky; Alan P Fields; Derek C Radisky
Journal:  Sci Transl Med       Date:  2012-07-11       Impact factor: 17.956

Review 7.  TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1.

Authors:  Breege V Howley; Philip H Howe
Journal:  Cytokine       Date:  2018-02-01       Impact factor: 3.861

Review 8.  Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.

Authors:  Laura M Urbanski; Nathan Leclair; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-04-25       Impact factor: 9.957

Review 9.  Matrix metalloproteinases as breast cancer drivers and therapeutic targets.

Authors:  Evette S Radisky; Derek C Radisky
Journal:  Front Biosci (Landmark Ed)       Date:  2015-06-01

10.  Differential Functions of Splicing Factors in Mammary Transformation and Breast Cancer Metastasis.

Authors:  SungHee Park; Mattia Brugiolo; Martin Akerman; Shipra Das; Laura Urbanski; Adam Geier; Anil K Kesarwani; Martin Fan; Nathan Leclair; Kuan-Ting Lin; Leo Hu; Ian Hua; Joshy George; Senthil K Muthuswamy; Adrian R Krainer; Olga Anczuków
Journal:  Cell Rep       Date:  2019-11-26       Impact factor: 9.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.